Management of opioid use disorder and associated conditions among hospitalized adults: A Consensus Statement from the Society of Hospital Medicine-Reference-Cited by-同舟云学术

Management of opioid use disorder and associated conditions among hospitalized adults: A Consensus Statement from the Society of Hospital Medicine

Published:2022-07-26 Issue:9 Volume:17 Page:744-756
ISSN:1553-5592
Container-title:Journal of Hospital Medicine
language:en
Short-container-title:Journal of Hospital Medicine

Author:

Calcaterra Susan L.¹^ORCID,Martin Marlene²^ORCID,Bottner Richard³,Englander Honora⁴,Weinstein Zoe⁵,Weimer Melissa B.⁶,Lambert Eugene⁷,Herzig Shoshana J.⁷⁸^ORCID

Affiliation:

1. Department of Medicine, Division of General Internal Medicine, Division of Hospital Medicine University of Colorado Aurora Colorado USA

2. Department of Medicine, Division of Hospital Medicine, San Francisco General Hospital University of California San Francisco San Francisco California USA

3. Department of Internal Medicine, Dell Medical School The University of Texas Austin Texas USA

4. Department of Medicine Section of Addiction Medicine, Division of Hospital Medicine Oregon Health and Science University Portland Oregon USA

5. Section of General Internal Medicine Boston University School of Medicine Boston Massachusetts USA

6. Department of Medicine Yale School of Medicine New Haven Connecticut USA

7. Department of Medicine Harvard Medical School, Division of General Internal Medicine, Massachusetts General Hospital Boston Massachusetts USA

8. Department of Medicine Beth Israel Deaconess Medical Center Boston Massachusetts USA

Funder

Agency for Healthcare Research and Quality

National Institute on Drug Abuse

Publisher

Wiley

Subject

Assessment and Diagnosis,Care Planning,Health Policy,Fundamentals and skills,General Medicine,Leadership and Management

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jhm.12893

Reference148 articles.

1. National Center for Health Statistics. Drug overdose deaths in the U.S. top 100 000 annually. Centers for Disease Control and Prevention. November 17 2021. Accessed May 22 2022.https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2021/20211117.htm

2. Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder

3. Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality

4. Geographic Distribution of Providers With a DEA Waiver to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder: A 5-Year Update

5. Buprenorphine Coverage in the Medicare Part D Program for 2007 to 2018

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pain Management in Patients With Opioid Use Disorder on Extended-release Buprenorphine: A Case Report;Journal of Addiction Medicine;2023-12-01

2. Point/counterpoint: Should full agonist opioid medications be offered to hospitalized patients for management of opioid withdrawal?;Journal of Hospital Medicine;2023-11-29

3. Strategies to support substance use disorder care transitions from acute-care to community-based settings: a scoping review and typology;Addiction Science & Clinical Practice;2023-11-02

4. Inpatient Opioid Withdrawal: A Qualitative Study of the Patient Perspective;2023-10-09

5. Continuation of Buprenorphine During Hospitalization and Subsequent Retention in Therapy: an Observational Study in Veterans Administration Hospitals;Journal of General Internal Medicine;2023-09-26